In2Bones Announces U.S. Launch of the Avenger Radial Head™ Prosthesis With Sterile, Single-Use Instruments

In2Bones Global, Inc. today announces the U.S. launch of the Avenger Radial Head™ Prosthesis System for primary and revision joint replacement of the radial head. The new prosthesis restores elbow joint function and provides several advantages to surgeons and patients compared with current prosthetic systems.

In2Bones notes this is the first radial head implant to include sterile, single-use instrumentation.

The modularity of the new Avenger Radial Head Prosthesis System — with multiple, highly-polished head and stem sizes — enables surgeons to restore the appropriate height of the radius, which may aid in elbow stability. The new System is also designed with a smooth stem, shown in multiple long-term studies to provide better clinical outcomes than press-fit, ingrowth radial head implant designs.1, 2

The elbow joint is often difficult to access during surgery due to swelling and inflammation caused by trauma. The Avenger System resolves this with tapered and short stem options, allowing for easier insertion and improved implant stability.

“I choose smooth stem radial head implants for my patients because they have shown to have better long-term results,” says Korsh Jafarnia, M.D., orthopedic surgeon and specialist in the hand and upper extremities at Houston Methodist Orthopedics & Sports Medicine. “The In2Bones Avenger Radial Head System is a modern, smooth stem design that is easier to implant due to the tapered and shorter stems.”

Radial head replacements are often performed during trauma surgery with little advanced notice. Thus, there can be tremendous benefits to providers who select implants that include sterile, single-use instruments. Benefits include:

  • Cost savings of as much as $400 per surgery
  • Increased efficiencies because long lead times and delays related to on-site sterilizing processes are bypassed
  • Reduced risks of surgical site infections (SSIs) post-operatively

“Having the instruments and implants sterile and ready to use provides costs savings for my hospital, and assures me that the system will be ready when I’m called in for surgery,” Dr. Jafarnia notes.

“Currently, radial head implant suppliers ship non-sterile instrument sets nationwide for short-notice cases, which can cause potential delays and can increase costs,” explains Jon Simon, Sr. Vice President of Marketing at In2Bones. “The Avenger Radial Head System can be placed on shelves and be ready for immediate use, on-demand. Additionally, surgeons and caregivers can be assured that the sharp, precision instrumentation will only ever contact one patient.”


References

1. T. Flinkkilä, T. Kaisto, K. Sirniö, P. Hyvönen, J. Leppilahti, J. of Bone and Joint Surgery, Short- to mid-term results of metallic press-fit radial head arthroplasty in unstable injuries of the elbow. VOL. 94-B, No. 6, JUNE 2012.

2. Grewal; J. Bone Joint Surg. 2006;88:2192-2200

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version